Changjiang Pharmaceutical Group Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 136.79 million compared to CNY 545.4 million a year ago. Revenue was CNY 136.79 million compared to CNY 545.4 million a year ago.

Net loss was CNY 22.96 million compared to net income of CNY 14.65 million a year ago. Basic loss per share from continuing operations was CNY 0.0655 compared to basic earnings per share from continuing operations of CNY 0.0418 a year ago. Diluted loss per share from continuing operations was CNY 0.0655 compared to diluted earnings per share from continuing operations of CNY 0.0418 a year ago.